The impact of intraperitoneal glucose and insulin on the liver.
Bargman
J M
JM
Department of Medicine, Toronto Hospital, Ontario, Canada.
D001786:Blood Glucose / Q000378:metabolism*; D003928:Diabetic Nephropathies / Q000503:physiopathology / Q000628:therapy; D005234:Fatty Liver / Q000503:physiopathology; D006801:Humans; D007274:Injections, Intraperitoneal; D007328:Insulin / Q000008:administration & dosage*; D007676:Kidney Failure, Chronic / Q000503:physiopathology* / Q000628:therapy; D008099:Liver / Q000187:drug effects* / Q000503:physiopathology; D010530:Peritoneal Dialysis; D010531:Peritoneal Dialysis, Continuous Ambulatory
D001786:Blood Glucose; D007328:Insulin